| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2018 | AEROPHASE INC | 401 MOUNTAIN VIEW AVE | LONGMONT | CO | 80501-3318 | BOULDER | USA | R43AI132067 | Treatment of NTM Respiratory Infections with Inhaled Drug Delivery | 000 | 2 | NIH | 12/18/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $150,000 ) |
| | 2018 | 2018 | AEROPHASE INC | 401 MOUNTAIN VIEW AVE | LONGMONT | CO | 80501-3318 | BOULDER | USA | R43AI132067 | Treatment of NTM Respiratory Infections with Inhaled Drug Delivery | 000 | 2 | NIH | 5/22/2018 | $150,000 |
|
| Issue Date FY: 2017 ( Subtotal = $300,000 ) |
| | 2017 | 2017 | AEROPHASE INC | 401 MOUNTAIN VIEW AVE | LONGMONT | CO | 80501-3318 | BOULDER | USA | R43AI132067 | Treatment of NTM Respiratory Infections with Inhaled Drug Delivery | 000 | 1 | NIH | 2/6/2017 | $300,000 |
|
| Issue Date FY: 2011 ( Subtotal = $0 ) |
| | 2011 | 2009 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 6 | NIH | 2/9/2011 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $775,040 ) |
| | 2009 | 2009 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 6 | NIH | 4/10/2009 | $775,040 |
| | 2009 | 2009 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 001 | 6 | NIH | 5/1/2009 | $0 |
| | 2009 | 2007 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44CA096409 | AEROSOL THERAPY FOR LUNG CANCER | 000 | 3 | NIH | 6/10/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $762,540 ) |
| | 2008 | 2008 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 5 | NIH | 4/9/2008 | $762,540 |
|
| Issue Date FY: 2007 ( Subtotal = $1,062,167 ) |
| | 2007 | 2007 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R43AI076196 | LOW COST PRODUCTION OF THE MALARIA DRUG ARTEMETHER | 000 | 1 | NIH | 7/20/2007 | $99,301 |
| | 2007 | 2007 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44CA096409 | AEROSOL THERAPY FOR LUNG CANCER | 000 | 3 | NIH | 7/23/2007 | $371,115 |
| | 2007 | 2007 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 4 | NIH | 3/15/2007 | $591,751 |
|
| Issue Date FY: 2006 ( Subtotal = $404,235 ) |
| | 2006 | 2006 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44CA096409 | AEROSOL THERAPY FOR LUNG CANCER | 000 | 2 | NIH | 7/1/2006 | $404,235 |
|
| Issue Date FY: 2003 ( Subtotal = $366,475 ) |
| | 2003 | 2003 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 3 | NIH | | $366,475 |
|
| Issue Date FY: 2002 ( Subtotal = $501,357 ) |
| | 2002 | 2002 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R43CA096409 | AEROSOL DELIVERY OF LUNG CANCER DRUGS | 000 | 1 | NIH | 9/3/2002 | $118,857 |
| | 2002 | 2002 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R44HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 2 | NIH | 4/26/2002 | $382,500 |
|
| Issue Date FY: 2001 ( Subtotal = $100,000 ) |
| | 2001 | 2001 | AEROPHASE CORPORATIION | 401 MOUNTAIN VIEW AVENUE | LONGMONT | CO | 80501 | BOULDER | USA | R43HL066830 | LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS | 000 | 1 | NIH | 3/7/2001 | $100,000 |
|
|
